Selegiline Hydrochloride Market

Selegiline Hydrochloride is the hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity.
Selegiline Hydrochloride Market aims to provide a comprehensive presentation of the global market for Selegiline Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Selegiline Hydrochloride. Selegiline Hydrochloride Market contains market size and forecasts of Selegiline Hydrochloride in global, including the following market information:
Global Selegiline Hydrochloride Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Selegiline Hydrochloride Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Selegiline Hydrochloride companies in 2022 (%)
The global Selegiline Hydrochloride market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Selegiline Hydrochloride include Somerset Pharmaceuticals Inc., Mylan Specialty, Draxis Health Inc., Deprenyl Research Ltd., Golden State Medical Supply, Mayne Pharma, Endo Pharmaceuticals, Par Pharmaceutical and Apotex Corp., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Selegiline Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Selegiline Hydrochloride Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Selegiline Hydrochloride Market Segment Percentages, by Type, 2022 (%)
Tablet
Capsule
Global Selegiline Hydrochloride Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Selegiline Hydrochloride Market Segment Percentages, by Application, 2022 (%)
Parkinson's disease
Depression
Global Selegiline Hydrochloride Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Selegiline Hydrochloride Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Selegiline Hydrochloride revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Selegiline Hydrochloride revenues share in global market, 2022 (%)
Key companies Selegiline Hydrochloride sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Selegiline Hydrochloride sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Somerset Pharmaceuticals Inc.
Mylan Specialty
Draxis Health Inc.
Deprenyl Research Ltd.
Golden State Medical Supply
Mayne Pharma
Endo Pharmaceuticals
Par Pharmaceutical
Apotex Corp.
A-S Medication Solutions
Outline of Major Chapters:
Chapter 1: Introduces the definition of Selegiline Hydrochloride, market overview.
Chapter 2: Global Selegiline Hydrochloride market size in revenue and volume.
Chapter 3: Detailed analysis of Selegiline Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Selegiline Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Selegiline Hydrochloride capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.